CD8A and neoplasm: One study applied an exploratory multiple fluorescence analysis to show that in patients with MSI-H, immune-combination chemotherapy increased tumor CD3+ and CD8+ T-cell densities, and that the degree of a pathological response was associated with increased clustering of CD3+ cells to panCK+ cells (33).